BRIVLERA

UCB Canada Inc🇨🇦 Health Canada

Approval Id: d6ce990f7143ee50
Drug Approval Canada Name: BRIVLERA
Product Name: BRIVLERA
Status: Marketed
Status Date: 2020-04-06
Original Market Date: 2020-04-06
Din: 02452987
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:12.92
Atc Original: N03AX23 BRIVARACETAM
Atc Name: n 03 ax 23
Aig Number: 0157931001
Company Name: UCB Canada Inc
Company Address: 602, 2201 Bristol Circle, Oakville, Ontario, Canada, L6H 0J8

BRIVARACETAM

10 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

d6ce990f7143ee50

Type

Standard